220 related articles for article (PubMed ID: 18948053)
1. The many faces of the SOCS box.
Piessevaux J; Lavens D; Peelman F; Tavernier J
Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.
Bullock AN; Debreczeni JE; Edwards AM; Sundström M; Knapp S
Proc Natl Acad Sci U S A; 2006 May; 103(20):7637-42. PubMed ID: 16675548
[TBL] [Abstract][Full Text] [Related]
3. Unbiased identification of substrates for the Epac1-inducible E3 ubiquitin ligase component SOCS-3.
Williams JJ; Palmer TM
Biochem Soc Trans; 2012 Feb; 40(1):215-8. PubMed ID: 22260693
[TBL] [Abstract][Full Text] [Related]
4. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
[TBL] [Abstract][Full Text] [Related]
5. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
6. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
[TBL] [Abstract][Full Text] [Related]
7. The suppressors of cytokine signalling (SOCS).
Kile BT; Alexander WS
Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
[TBL] [Abstract][Full Text] [Related]
8. SOCS proteins in regulation of receptor tyrosine kinase signaling.
Kazi JU; Kabir NN; Flores-Morales A; Rönnstrand L
Cell Mol Life Sci; 2014 Sep; 71(17):3297-310. PubMed ID: 24705897
[TBL] [Abstract][Full Text] [Related]
9. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
Linossi EM; Nicholson SE
IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
[TBL] [Abstract][Full Text] [Related]
10. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).
Bulatov E; Martin EM; Chatterjee S; Knebel A; Shimamura S; Konijnenberg A; Johnson C; Zinn N; Grandi P; Sobott F; Ciulli A
J Biol Chem; 2015 Feb; 290(7):4178-91. PubMed ID: 25505247
[TBL] [Abstract][Full Text] [Related]
11. Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation.
Bullock AN; Rodriguez MC; Debreczeni JE; Songyang Z; Knapp S
Structure; 2007 Nov; 15(11):1493-504. PubMed ID: 17997974
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
[TBL] [Abstract][Full Text] [Related]
13. The C-terminus of CIS defines its interaction pattern.
Lavens D; Ulrichts P; Catteeuw D; Gevaert K; Vandekerckhove J; Peelman F; Eyckerman S; Tavernier J
Biochem J; 2007 Jan; 401(1):257-67. PubMed ID: 16961462
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling.
Nicholson SE; Metcalf D; Sprigg NS; Columbus R; Walker F; Silva A; Cary D; Willson TA; Zhang JG; Hilton DJ; Alexander WS; Nicola NA
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2328-33. PubMed ID: 15695332
[TBL] [Abstract][Full Text] [Related]
15. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.
Babon JJ; Yao S; DeSouza DP; Harrison CF; Fabri LJ; Liepinsh E; Scrofani SD; Baca M; Norton RS
FEBS J; 2005 Dec; 272(23):6120-30. PubMed ID: 16302975
[TBL] [Abstract][Full Text] [Related]
16. The suppressors of cytokine signalling E3 ligases behave as tumour suppressors.
Elliott J; Hookham MB; Johnston JA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):464-8. PubMed ID: 18481982
[TBL] [Abstract][Full Text] [Related]
17. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases.
Muniz JR; Guo K; Kershaw NJ; Ayinampudi V; von Delft F; Babon JJ; Bullock AN
J Mol Biol; 2013 Sep; 425(17):3166-77. PubMed ID: 23806657
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
19. Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma.
Keller KE; Wirtz MK
Exp Eye Res; 2017 May; 158():154-160. PubMed ID: 27296073
[TBL] [Abstract][Full Text] [Related]
20. The SOCS box: a tale of destruction and degradation.
Kile BT; Schulman BA; Alexander WS; Nicola NA; Martin HM; Hilton DJ
Trends Biochem Sci; 2002 May; 27(5):235-41. PubMed ID: 12076535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
